| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.094 | 0.03 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.04 |
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | 0.096 | 0.04 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.11 | 0.04 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.04 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | 0.098 | 0.04 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | -0.26 | 0.04 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | 0.11 | 0.04 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | 0.096 | 0.05 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | 0.09 | 0.05 |